Publication Name	World Journal of Clinical Cases
Manuscript ID	2258
Country	Japan

Received	2013-02-11 15:30
Peer-Review Started	2013-02-13 12:58
First Decision by Editorial Office Director
Return for Revision	2013-03-28 22:11
Revised
Publication Fee Transferred
Second Decision by Editor	2013-04-10 16:55
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2013-04-11 05:15
Articles in Press
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-05-14 21:42
Publish the Manuscript Online	2013-05-16 14:52

ISSN	2307-8960 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Synchronous rectal and esophageal cancer treated with chemotherapy followed by two-stage resection
Manuscript Source	Invited Manuscript
All Author List	Setsuo Utsunomiya, Keisuke Uehara, Takuya Kurimoto, Ken Hirose, Masahide Fukaya, Yu Takahashi, Yoshiro Taguchi, Keita Itatsu and Masato Nagino
Funding Agency and Grant Number
Corresponding Author	Keisuke Uehara, MD, PhD, Division of Surgical Oncology, Department of Surgery, Nagoya Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. kuehara@med.nagoya-u.ac.jp
Key Words	Rectal cancer; Esophageal cancer; Neoadjuvant chemotherapy; Cetuximab; Oxaliplatin
Core Tip	In case with synchronous multiple cancers, it is sometimes difficult to identify the origin especially when liver and/or pulmonary lesions have a possibility of metastases, or to decide on a course or priority of the treatment. FOLFOX + cetuximab (Cet) therapy could provide a favorable control of not only rectal origin accompanied by liver metastases but also esophageal cancer, which made possible to undergo two-stage curative resection. FOLFOX + Cet regimen might be a useful option for such refractory rectal and esophageal cancer.
Publish Date	2013-05-16 14:52
Citation	Utsunomiya S, Uehara K, Kurimoto T, Hirose K, Fukaya M, Takahashi Y, Taguchi Y, Itatsu K, Nagino M. Synchronous rectal and esophageal cancer treated with chemotherapy followed by two-stage resection. World J Clin Cases 2013; 1(2): 87-91
URL	http://www.wjgnet.com/2307-8960/full/v1/i2/87.htm
DOI	http://dx.doi.org/10.12998/wjcc.v1.i2.87

Full Article (PDF)	WJCC-1-87.pdf
Manuscript File	2258-Review.docx
Answering Reviewers	2258-Answering reviewers.pdf
Copyright License Agreement	2258-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	2258-Language certificate.pdf
Peer-review Report	2258-Peer review.pdf
Scientific Editor Work List	2258-Scientific editor work list.doc